HK1060855A1 - Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function - Google Patents

Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Info

Publication number
HK1060855A1
HK1060855A1 HK04103932A HK04103932A HK1060855A1 HK 1060855 A1 HK1060855 A1 HK 1060855A1 HK 04103932 A HK04103932 A HK 04103932A HK 04103932 A HK04103932 A HK 04103932A HK 1060855 A1 HK1060855 A1 HK 1060855A1
Authority
HK
Hong Kong
Prior art keywords
ofdelayed
medicament
manufacture
treatment
graft function
Prior art date
Application number
HK04103932A
Other languages
English (en)
Inventor
Marc Bigaud
Volker Brinkmann
Tomasz Sablinski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0104438A external-priority patent/GB0104438D0/en
Priority claimed from GB0105000A external-priority patent/GB0105000D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1060855A1 publication Critical patent/HK1060855A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04103932A 2001-02-22 2004-06-01 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function HK1060855A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0104438A GB0104438D0 (en) 2001-02-22 2001-02-22 Organic compounds
GB0105000A GB0105000D0 (en) 2001-02-28 2001-02-28 Organic compounds
PCT/EP2002/001860 WO2002067915A1 (en) 2001-02-22 2002-02-21 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function

Publications (1)

Publication Number Publication Date
HK1060855A1 true HK1060855A1 (en) 2004-08-27

Family

ID=26245749

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103932A HK1060855A1 (en) 2001-02-22 2004-06-01 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Country Status (12)

Country Link
US (2) US20040087662A1 (xx)
EP (1) EP1368015B1 (xx)
JP (1) JP4318921B2 (xx)
CN (1) CN100479814C (xx)
AT (1) ATE335475T1 (xx)
BR (1) BR0207434A (xx)
CA (1) CA2435739A1 (xx)
DE (1) DE60213766T2 (xx)
ES (1) ES2267993T3 (xx)
HK (1) HK1060855A1 (xx)
PT (1) PT1368015E (xx)
WO (1) WO2002067915A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002320828B2 (en) * 2001-06-08 2006-02-02 Novartis Ag Treatment or prophylaxis of insulin-producing cell graft rejection
NZ533994A (en) 2002-01-11 2006-10-27 Sankyo Co Amino alcohol derivative or phosphonic acid derivative and medicinal compostion containing these
AU2005215320B2 (en) 2004-02-24 2008-04-17 Sankyo Company, Limited Amino alcohol compound
CN101905023B (zh) * 2004-07-16 2012-07-11 杏林制药株式会社 有效的医药使用方法及与副作用发生的防御相关的方法
US7795472B2 (en) * 2004-10-12 2010-09-14 Kyorin Pharmaceutical Co., Ltd. Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride and hydrates thereof, and intermediates in the production thereof
US8048928B2 (en) * 2005-10-07 2011-11-01 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
NZ574011A (en) * 2006-08-08 2011-10-28 Kyorin Seiyaku Kk Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
SG174029A1 (en) * 2006-08-08 2011-09-29 Kyorin Seiyaku Kk Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
WO2009099174A1 (ja) 2008-02-07 2009-08-13 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928572A (en) * 1971-02-11 1975-12-23 Ayerst Mckenna & Harrison Myriocin and process of preparation
EP0627406B1 (en) * 1992-10-21 1998-10-28 Yoshitomi Pharmaceutical Industries, Ltd. 2-amino-1,3-propanediol compound and immunosuppressant
CZ285953B6 (cs) * 1995-12-28 1999-12-15 Yoshitomi Pharmaceutical Industries, Ltd. Vnější přípravek pro topické podání
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
KR100551931B1 (ko) * 1997-04-04 2006-02-16 미츠비시 웰파마 가부시키가이샤 2-아미노프로판-1,3-디올 화합물, 이것의 의약으로서의 용도 및 합성 중간체
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
AU2002320828B2 (en) * 2001-06-08 2006-02-02 Novartis Ag Treatment or prophylaxis of insulin-producing cell graft rejection

Also Published As

Publication number Publication date
JP2004527490A (ja) 2004-09-09
DE60213766D1 (de) 2006-09-21
ES2267993T3 (es) 2007-03-16
US20080015261A1 (en) 2008-01-17
BR0207434A (pt) 2004-07-06
EP1368015B1 (en) 2006-08-09
DE60213766T2 (de) 2007-08-02
PT1368015E (pt) 2006-12-29
JP4318921B2 (ja) 2009-08-26
ATE335475T1 (de) 2006-09-15
CN1492757A (zh) 2004-04-28
CN100479814C (zh) 2009-04-22
WO2002067915A1 (en) 2002-09-06
EP1368015A1 (en) 2003-12-10
CA2435739A1 (en) 2002-09-06
US20040087662A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
WO2004039248A3 (en) Repairing or replacing tissues or organs
AU2001273276A1 (en) Improving effectiveness of medical stents by gcib
TW200714283A (en) Method and composition for treating peripheral vascular diseases
UA88418C2 (ru) Синергическая фунгицидная комбинация активных веществ и их применение для борьбы с нежелательными фитопатогенными грибами
DE60235928D1 (de) Mittel zur Suppression von Transplantat-Abstossung
PL1646634T3 (pl) Zastosowanie rapamycyny i pochodnych rapamycyny w leczeniu utraty kości
HK1047404B (zh) 血管膜合成物
WO2007149999A3 (en) Compositions and methods for joining non-conjoined lumens
MXPA06000123A (es) Suspension aislante de apoyo central de resorte rapido de plastico y metodo para fabricar y ensamblar el mismo.
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
WO2003103662A3 (en) GLYCOPROTEIN VI INHIBITORS
HK1060855A1 (en) Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
EP1162956B8 (en) Compositions and methods for improving integrity of compromised body passageways and cavities
DE60335202D1 (en) Chaperonin-10-immunosuppression
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
MXPA04003755A (es) Endoprotesis vasculares.
WO2004091436A3 (en) Methods and compositions for treating ocular disease
GB2454154A (en) Aglet for attachment to a graft material
WO2007016580A3 (en) Silencing rna molecules and their use in bone formation
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
TW200514553A (en) Therapeutic agent for hepatitis C
NZ332412A (en) use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
IL169784A0 (en) Spermicidal and fungicidal compositions containing hexahydroindenopyridine derivatives and methods utilizing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100221